The rat .8 nerve growth factor (NGF) gene was inserted into a mammalian expression vector and cotransfected with a plasmid conferring resistance to neomycin into mouse 3T3 fibroblasts. From this transfection a stable cell line was selected that contains several hundred copies of the rat NGF gene and produces excess levels of recombinant NGF. Such genetically modified cells were implanted into the rat brain as a probe for in vivo effects of NGF on central nervous system neurons. In a model of the cortical cholinergic deficits in Alzheimer disease, we demonstrate a marked increase in the survival of, and fiber outgrowth from, grafts of fetal basal forebrain cholinergic neurons, as well as stimulation of fiber formation by intact adult intrinsic cholinergic circuits in the cerebral cortex. Adult cholinergic interneurons in intact striatum also sprout vigorously toward implanted fibroblasts. Our results suggest that this model has implications for future treatment of neurodegenerative diseases.
Nerve growth factor (NGF) is a target-derived protein that in the peripheral nervous system is required for the development and maintenance of sympathetic and sensory neurons (1, 2) . NGF mediates its neurotrophic effects by interacting with specific NGF receptors, and, in the central nervous system, basal forebrain cholinergic neurons have NGF receptors (3, 4) and retrogradely transport exogenous NGF (5, 6) . Target areas of these neurons, the hippocampus and cortex, contain the highest levels of NGF mRNA in the brain (7) (8) (9) (10) . The adult basal forebrain cholinergic neurons respond to exogenous NGF by increasing the levels of choline acetyltransferase, the key enzyme in acetylcholine synthesis (11) (12) (13) (14) . Cholinergic neurons in the medial septum can be prevented from degeneration after transection of the septohippocampal pathway by chronic infusion of exogenous NGF (15) (16) (17) .
The basal forebrain cholinergic system is associated with cognitive functions and in rodents a strong correlation exists between impairments in learning and memory and atrophy of cholinergic neurons (18) (19) (20) . A loss of forebrain cholinergic neurons occurs during normal aging (18) and it is conceivable, although by no means proven, that the age-dependent atrophy is caused by a deficient supply or utilization of one or several trophic factor(s). Interestingly, the levels of both NGF mRNA and protein are significantly reduced in the forebrain of aged rats (21) . In addition, intracerebral infusion of NGF in aged rats reduces basal forebrain cholinergic neuron atrophy and results in an improved spatial memory in behaviorally impaired rats (22) .
A pronounced loss of cholinergic neurons in the basal forebrain is seen in Alzheimer senile dementia and the corresponding degeneration of cholinergic terminals in cortical areas is thought to be causally linked to the progressive loss of memory and other cognitive disturbancies characteristic of the disease (18) (19) (20) (23) (24) (25) . Although there is no direct experimental evidence to suggest that NGF can reduce or prevent degeneration of basal forebrain cholinergic neurons in neurodegenerative diseases such as Alzheimer disease, the results obtained so far from animal experiments suggest that NGF could indeed be used for this purpose.
As a step toward the possible therapeutical application of NGF, we report on the implantation into the rat brain of genetically modified cells that produce recombinant NGF. The implanted cells caused a marked increase in the survival of and fiber outgrowth from both grafted fetal basal forebrain acetylcholinesterase (AChE)-positive neurons as well as a marked fiber growth response from intrinsic cholinergic neurons in both cerebral cortex and striatum. Hence, our results show that NGF can function in vivo as a neurotrophic factor for several populations of central cholinergic neurons. Furthermore, it is suggested that techniques similar to those described here to administer NGF into the brain can be used for treatment of neurodegenerative diseases.
MATERIALS AND METHODS
Isolation of a Genetically Modified Cell Line That Produces Excess Levels of Recombinant NGF. The 3' exon of the rat NGF gene (26) was digested with BstEII and Pst I, and a 771-base-pair fragment was isolated and blunt-ended using T4 DNA polymerase. Pst I linkers were ligated to the fragment followed by insertion into the Pst I site of the plasmid MRE-(4x)-OVEC (27) . The ligation mixture was transformed into Escherichia coli MC1061. The plasmid containing the rat NGF gene in the correct orientation for translation was purified and cotransfected with a plasmid containing a neomycin-resistance gene (molar ratio of OVEC-NGF to neomycin plasmid = 10:1) into mouse fibroblast 3T3 cells using the Ca3(P04)2/glycerol technique (28) . Transfected cells resistant to the neomycin analogue G418 (1.5 mg/ml) were isolated by serial dilution and conditioned medium from the resulting cell clones were assayed for NGF using chicken sympathetic ganglia (29 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. 0.14 M 2-mercaptoethanol, followed by centrifugation on a cushion of 5.7 M CsCl in 0.025 M sodium acetate (pH 5.0). The cellular DNA and RNA were separately collected from the gradient and ethanol-precipitated. The DNA was digested with BamHI, and separated on a 0.8% agarose gel followed by transfer to a nitrocellulose filter. The RNA was separated on a 1% agarose gel containing 0.7% formaldehyde and then transferred to a nitrocellulose filter. Both the DNA and the RNA blots were hybridized to the rat NGF 771-base-pair BstEII-Pst I fragment labeled with [a-32P]dCTP by nicktranslation, followed by high-stringency washing and exposure to x-ray film.
Implantation of NGF-Transfected Cells into the Rat Brain. Under halothane anesthesia, Sprague-Dawley rats weighing 280-350 g received 1 jul of ibotenic acid (5 Ag/IAI) into nucleus basalis magnocellularis using the following stereotaxic coordinates (relative to bregma, in mm): AP, 0.8-1.0; L, 2.4-2.6; V, 6.4-6.6. Infusions were made over a 2-min interval with an additional 5 min to allow for diffusion prior to withdrawal of the syringe. The 3E and 3T3 cells were grown in vitro in DMEM containing 10% fetal calf serum. For grafting, they were mixed with a dissociated cell suspension of basal forebrain tissue including nucleus basalis magnocellularis from fetal rats at embryonic day 17 to 18. Three weeks after the ibotenic acid lesion, cell mixtures were implanted at several positions in cholinergically denervated (26) was inserted into the Pst I site of the mammalian expression vector MRE-(4x)-OVEC (27) . (Fig. la) . This construct was cotransfected with a neomycin-resistance plasmid into mouse fibroblasts 3T3 cells. Conditioned medium from cells resistant to the neomycin analogue G418 was tested for enhanced stimulation of fiber outgrowth from embryonic chicken sympathetic ganglia (29) . Southern blot analysis of genomic DNA from one transfected cell line (3E) that produced biologically active NGF revealed the presence of several hundred copies of the rat NGF gene (Fig. lb) . This cell line also expressed a 2.2-kilobase (kb) NGF-hybridizing transcript (Fig. ic) . The size of this transcript is consistent with transcription from the upstream "TATA box," terminating around the hexanucleotide sequence AATAAA in the rabbit 83-globin gene. The level of the 2.2-kb transcript was approximately 50 times higher than the level of endogenous NGF mRNA produced in the parental 3T3 cells. Conditioned medium from the 3E cells readily stimulated fiber outgrowth from chicken sympathetic ganglia (Fig. ld) the cortical cholinergic deficits of Alzheimer disease, the frontoparietal cholinergic projection from the anterior twothirds of nucleus basalis to cerebral cortex was unilaterally lesioned by stereotaxic injection of ibotenic acid. The injection caused a greater than 90% reduction of cholinergic cells in nucleus basalis and a marked unilateral reduction in density of cholinergic fibers in frontal and parietal cortex as revealed by immunohistochemistry using antibodies against AChE and AChE histochemistry. 3E cells, or parental 3T3 cells as control, were mixed with a dissociated cell suspension of fetal basal forebrain tissue including nucleus basalis magnocellularis from day 17 to 18 of gestation. These mixtures were implanted into denervated cerebral cortices. Counts of cholinergic nerve cell bodies from 4 weeks after implantation showed that 3E cells increased survival, as assessed by AChE staining, about 10-fold compared to parental 3T3 cells (Fig. 2a) . When cholinergic cells were grafted adjacent to an implant of 3E cells, survival increased approximately 5-fold, as compared to a 3T3-cell implant. In addition to increased survival, 3E cells also stimulated fiber outgrowth from grafted AChE-positive neurons into host brain parenchyma (Figs. 2a and 3) . The 3E cells also had a marked stimulatory effect on local intrinsic AChE-positive fibers in cerebral cortex. Hence, implants of 3E cells alone into cholinergically denervated cortex signif- icantly increased density of intrinsic cholinergic innervation in a halo around the implants (Fig. 3) . No change in nerve density was seen around similar implants of parental 3T3 cells.
NGF Responsiveness of Adult Cholinergic Interneurons in Striatum. To clarify the possible role of NGF in supporting intrinsic cholinergic neurons in striatum, collagen gels (29) containing 3E cells were implanted into intact striatum on one side of the rat brain and similar gels containing the parental cell line on the other side. As in cortical experiments, 3E cells caused a markedly increased density of cholinergic nerve terminals in a zone around implants, as evaluated by AChE antibody immunohistochemistry (Fig. 2 b and c) . This was seen in five out of six cases 3-7 weeks after implantation. In addition, AChE-positive nerve fibers often invaded the implanted gel containing 3E cells. Implantation of a gel containing parental 3T3 cells, or a gel without any cells, caused no increase in AChE-positive nerve fibers (Fig. 2 d and e) . To evaluate viability of grafted 3T3 cells, alternate sections from striatal implants were analyzed using antibodies against fibronectin. Seven weeks after grafting, both parental 3T3 cells and 3E cells formed dense extracellular networks of fibronectin-positive fibers.
DISCUSSION
Exocrine sources, in particular the male mouse submandibular gland, have for many years been used to obtain purified NGF protein (32). We have established and used an alternative source for NGF, namely a genetically modified cell line that produces excess levels of biologically active recombinant NGF when cultured in vitro and evokes a neurotrophic effect in vivo. Parts of this work have been reported (33) in abstract form. In the recombinant NGF-producing 3E cell line, the rat NGF gene is transcribed from a rabbit f8-globin promoter that has been modified by insertion of a heavy metal-inducible enhancer motif. However, when cultured in vitro, the 3E cells express NGF mRNA and protein apparently independent of the concentrations of heavy metals, suggesting that the metal-inducible enhancer motif has no effect on (18) (19) (20) (23) (24) (25) . However, it is unlikely that this degeneration is caused by a deficit in NGF or its receptor since the mRNA levels of both NGF and its receptor appear to be unaltered in postmortem brain samples from Alzheimer patients, compared to age-matched controls (38, 39) . The persistence of NGF receptors on basal forebrain cholinergic neurons could be explained by the finding that these neurons do not appear to die in the course of the disease but instead undergo atrophy (40 
